CYSVIEW KIT (Hexaminolevulinate Hydrochloride) Patent Expiration, LOE Window & CMS Spending

CYSVIEW KIT (Hexaminolevulinate Hydrochloride) by Photocure Asa: FDA Orange Book LOE 2038-01-04, 0 AB generics, $0 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorPhotocure Asa
FDA Application & PathwayN022555 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2038-01-04
Orange Book Patents (*PED Extensions)3 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$0
2024 Medicare Part D Spend$0
2024 Medicaid Spend$0
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel